Sleep-specific DBS Therapy in Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood. Results from this study will provide a better understanding of the brain circuitry involved in disordered sleep in PD and inform the development of targeted therapeutic interventions to treat sleep disorders in people with neurodegenerative disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Healthy Volunteers: f
View:

• Diagnosis of idiopathic PD

• At least 21 years old

• Existing or planned 7T brain imaging

• Surgery at UMN to implant DBS system in GPi or STN with directional lead(s) is planned as part of routine clinical care

• Surgery at UMN to implant bilateral DBS system in GPi or STN with directional lead(s) is planned as part of routine clinical care (or has already occurred, as long as the initial programming session is at least 2 weeks away)

Locations
United States
Minnesota
University Of Minnesota
RECRUITING
Minneapolis
Contact Information
Primary
Luke Johnson, PhD
joh03032@umn.edu
612-625-9900
Backup
Peter M Grund, BS
grund130@umn.edu
763-347-1287
Time Frame
Start Date: 2023-06-22
Estimated Completion Date: 2027-08-01
Participants
Target number of participants: 64
Treatments
Experimental: OFF DBS followed by ON DBS
Experimental: ON DBS followed by OFF DBS
Sponsors
Leads: University of Minnesota

This content was sourced from clinicaltrials.gov